Skip to main content

New Avenue for Parkinson’s Disease Research


Nearly 60,000 Americans are diagnosed with Parkinson’s disease each year, resulting in a $52 Billion annual economic burden to the U.S. government. Parkinson’s disease is typified by the toxic aggregation of a presynaptic protein called alpha-Synuclein. Research published recently by the Mattoo lab shows a role for the human Fic protein, HYPE, in preventing aggregation of alpha-Synuclein. This novel link between HYPE and alpha-Synuclein opens exciting new avenues of research towards developing therapeutics for Parkinson’s disease. 

Press Coverage links:


Manuscript link:

Purdue University Biological Sciences, 915 Mitch Daniels Boulevard, West Lafayette, IN 47907

Main Office: (765) 494-4408   Business Office: (765) 494-4764  Contact Us

© 2024 Purdue University | An equal access/equal opportunity university | Copyright Complaints

Trouble with this page? Disability-related accessibility issue? Please contact the College of Science Webmaster.

Maintained by Science IT